Cited by 248Streptococcal Infections and TreatmentsSystemic Lupus Erythematosus ResearchViral Infections and Immunology Research

Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin

Open access
Galvin, Jeffrey E., Hemric, Mark E., Ward, Kent, Cunningham, Madeleine W.·2000·Journal of Clinical Investigation

Abstract

Anti-streptococcal antibodies cross-reactive with N-acetyl-betaD-glucosamine (GlcNAc) and myosin are present in the sera of patients with rheumatic fever (RF). However, their role in tissue injury is not clear. In this study, we show that anti-GlcNAc/anti-myosin mAb 3.B6 from a rheumatic carditis patient was cytotoxic for human endothelial cell lines and reacted with human valvular endothelium and underlying basement membrane. Reactivity of mAb 3.B6 with the valve was inhibited by human cardiac myosin > laminin > GlcNAc. The mAb 3.B6 epitopes were localized in fragments of human cardiac myosin, including heavy meromyosin (HMM), the S1 subfragment, and two light meromyosin (LMM) peptides containing amino acid sequences KEALISSLTRGKLTYTQQ (LMM 1) and SERVQLLHSQNTSLINQK (LMM 33). A novel feature of mAb 3.B6 was its reactivity with the extracellular matrix protein laminin, which may explain its reactivity with the valve surface. A laminin A-chain peptide (HTQNT) that includes homology to LMM33 inhibited the reactivity of mAb 3.B6 with human valve. These data support the hypothesis that cross-reactive antibodies in rheumatic carditis cause injury at the endothelium and underlying matrix of the valve.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci7132

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Galvin, J. E., Hemric, M. E., Ward, K., & Cunningham, M. W.
Affiliations
University of Oklahoma Health Sciences Center (US)
Corresponding author
Cunningham, Madeleine W.
Venue
Journal of Clinical Investigation
Published
2000-07-15
Volume
106
Issue
2
Pages
217-224
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2075460902
Cited by
248
References
46
Citations by year
2026: 11 · 2025: 12 · 2024: 7 · 2023: 11 · 2022: 7 · 2021: 8 · 2020: 9 · 2019: 10 · 2018: 11 · 2017: 9 · 2016: 15 · 2015: 6 · 2014: 13 · 2013: 10 · 2012: 7
FWCI
8.99
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Commons (Liberty University) (submittedVersion)
Funders
  • University of Oklahoma
  • University of Oklahoma Health Sciences Center
  • National Heart, Lung, and Blood Institute (R56HL056267, R01HL056267, R37HL035280, HL-56267, HL35280)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Streptococcal Infections and Treatments
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
Keywords
rheumatic carditis, rheumatic fever, streptococcal antibodies, anti-myosin antibodies, cytotoxic antibodies, heart valves, laminin, cardiac myosin, light meromyosin, heavy meromyosin, basement membrane, extracellular matrix, antibody cross-reactivity, endothelial injury
MeSH terms
Acetylglucosamine, Adolescent, Amino Acid Sequence, Antibodies, Monoclonal, Cytotoxicity, Immunologic, Endothelium, Vascular, Enzyme-Linked Immunosorbent Assay, Heart Valves, Humans, Laminin, Male, Molecular Sequence Data, Myocarditis, Myosins, Peptide Fragments, Rheumatic Heart Disease, Epitope Mapping, Molecular Mimicry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review